drugset / Trial / NCT00576368

An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice

NCT00576368 ↗

Phase 4 Completed 4464 enrolled Sanofi
RandomizedSingle-groupOpen-labelTreatment

Summary

The objective of this survey on this registered product is to confirm the efficacy, and safety profile of Lantus in every day medical practice. This program will also help to obtain information about the use of the insulin titration regimen and handling of the Lantus insulin analogue.

Timeline

Start
2003-06
Primary completion
—
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin glargine Protein / enzyme biologic — Subcutaneous

Indications